Effect of a thrombopoietin receptor agonist on use of intravenous immune globulin in patients with immune thrombocytopenia-Reference-Cited by-同舟云学术

Effect of a thrombopoietin receptor agonist on use of intravenous immune globulin in patients with immune thrombocytopenia

Published:2015-09-24 Issue:1 Volume:56 Page:73-79
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Zeller Michelle P.¹²,Heddle Nancy M.¹³,Kelton John G.¹,Hamilton Korinne³,Wang Grace³,Sholapur Naushin³⁴,Carruthers Julie³,Hsia Cyrus⁵,Blais Normand⁶,Toltl Lisa¹,Hamm Caroline⁷,Pearson Marc-André⁶,Arnold Donald M.¹²

Affiliation:

1. Department of Medicine Michael G. DeGroote School of Medicine; McMaster University; Hamilton Ontario

2. Canadian Blood Services

3. McMaster Transfusion Research Program; Hamilton Ontario Canada

4. Health Research Methodology, Department of Clinical Epidemiology and Biostatistics; McMaster University

5. Department of Medicine Division of Hematology; London Health Sciences Centre; London Ontario Canada

6. Department of Hemato-Oncology; Montreal University; Montreal Quebec Canada

7. Windsor Regional Cancer Program; Windsor Regional Hospital; Windsor Ontario Canada.

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/trf.13336/fullpdf

Reference27 articles.

1. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group;Rodeghiero;Blood,2009

2. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood;Imbach;Lancet,1981

3. Long-term observation of 208 adults with chronic idiopathic thrombocytopenic purpura;Stasi;Am J Med,1995

4. Overview of 321 patients with idiopathic thrombocytopenic purpura. Retrospective analysis of the clinical features and response to therapy;Pamuk;Ann Hematol,2002

5. Intravenous immunoglobulin for adults with autoimmune thrombocytopenic purpura: results of a randomized trial comparing 0.5 and 1 g/kg b.w;Godeau;Br J Haematol,1999

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thrombopoietin Receptor Agonists and Other Second-Line Therapies for Immune Thrombocytopenia: A Narrative Review With a Focus on Drug Access in Canada;Clinical and Investigative Medicine;2024-03-01

2. A cost–utility analysis of thrombopoietin receptor agonists for treating pediatric immune thrombocytopenia purpura after failure of first‐line therapies;Pediatric Blood & Cancer;2023-06-30

3. Mechanisms and therapeutic prospects of thrombopoietin receptor agonists;Seminars in Hematology;2019-10

4. Development and implementation of a novel immune thrombocytopenia bleeding score for dogs;Journal of Veterinary Internal Medicine;2018-04-21

5. Dynamic dosing of romiplostim in patients with immune thrombocytopenia purpura: Two case reports;Journal of Oncology Pharmacy Practice;2018-01-22